William Blair restated their outperform rating on shares of Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) in a report ...

Equities researchers at William Blair increased their FY2026 EPS estimates for argenx in a research note issued on Friday, ...

William Blair reiterated their outperform rating on shares of Vital Farms (NASDAQ:VITL – Free Report) in a report published on Friday morning,RTT News reports. William Blair also issued estimates for ...

Analysts at William Blair issued their Q1 2025 earnings per share estimates for First Solar in a note issued to investors on ...

Analysts at William Blair issued their Q1 2026 earnings per share (EPS) estimates for shares of MDxHealth in a research ...

Fintel reports that on February 28, 2025, William Blair initiated coverage of Corbus Pharmaceuticals Holdings (NasdaqCM:CRBP) ...

Fintel reports that on February 28, 2025, William Blair initiated coverage of Altimmune (NasdaqGM:ALT) with a Market Perform ...

Fintel reports that on February 28, 2025, William Blair initiated coverage of Terns Pharmaceuticals (NasdaqGS:TERN) with a ...

We recently published a list of 8 Worst Performing Mutual Funds in 2024. In this article, we are going to take a look at ...

William Blair started coverage on shares of Structure Therapeutics (NASDAQ:GPCR – Free Report) in a research note published on Friday, Marketbeat Ratings reports. The brokerage issued an outperform ...

Investment analysts at William Blair boosted their Q3 2026 earnings per share (EPS) estimates for shares of Salesforce in a ...

William Blair issued their Q1 2026 earnings estimates for shares of Verve Therapeutics in a report issued on Thursday, ...